Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DataMeds AI, Inc.WGRX · Entity 8434 | Chief Clinical Officer | March 21, 2025 | March 25, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DataMeds AI, Inc.
Report date March 21, 2025 · Filed March 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, Par Value $0.0001SEC Table I · non-derivative | Direct | 102,080 |
Reported balance
After 2025-03-21 transaction · row 1
1 source rowRow 1 · 2025-03-21 · Grant · Acquired 35,000 · Balance 102,080 F1: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 15,000 shares vesting immediately, 10,000 shares vesting on October 1, 2026, and 10,000 shares vesting on October 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 15,000 shares vesting immediately, 10,000 shares vesting on October 1, 2026, and 10,000 shares vesting on October 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2025 Filed Mar 25, 2025 16:21 UTC | DataMeds AI, Inc. WGRX · Entity 8434 | GrantCommon Stock, Par Value $0.0001 | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000603 · ownership.xml · nonDerivative · entry 1 Pirani Shafaat · CIK 0002058548 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,080 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 15,000 shares vesting immediately, 10,000 shares vesting on October 1, 2026, and 10,000 shares vesting on October 1, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.